A Ruptured Left Gastric Artery Aneurysm That Neoplasticized during the Course of Coronavirus Disease 2019: A Case Report.
Satoshi AnoYuto ShinkuraTsuneaki KenzakaNaoaki KusunokiSatoru KawasakiHogara NishisakiPublished in: Pathogens (Basel, Switzerland) (2022)
Coronavirus disease 2019 (COVID-19) is an acute respiratory syndrome caused by SARS-CoV-2 and is known to cause respiratory and systemic symptoms. A SARS-CoV-2 infection is involved in aneurysm formation, enlargement, and rupture in medium-sized vessels, such as the cerebral and coronary arteries and the aorta. In contrast, its involvement in forming aneurysms in medium-sized vessels other than the cerebral and coronary arteries has not been reported. An 84-year-old Japanese man with COVID-19 was admitted to our hospital. The treatment course was favorable, and the COVID-19 treatment was completed by the 10th day. On day 14, pancreatic enzymes increased mildly. An abdominal computed tomography revealed a ruptured left gastric aneurysm after spontaneous hemostasis. Arterial embolization was performed. In this patient, a new left gastric aneurysm was suspected of having formed and ruptured during the course of the COVID-19 treatment. To the best of our knowledge, this is the first report of abdominal visceral aneurysm formation caused by COVID-19 in a medium-sized vessel, and it is necessary to remember that aneurysms can be formed at any site when treating this syndrome.
Keyphrases
- coronavirus disease
- sars cov
- coronary artery
- respiratory syndrome coronavirus
- abdominal aortic aneurysm
- computed tomography
- subarachnoid hemorrhage
- healthcare
- pulmonary artery
- coronary artery disease
- case report
- emergency department
- type diabetes
- physical activity
- pulmonary embolism
- intensive care unit
- magnetic resonance imaging
- brain injury
- left ventricular
- depressive symptoms
- insulin resistance
- adipose tissue
- sleep quality
- smoking cessation
- aortic stenosis
- replacement therapy
- acute care
- transcatheter aortic valve replacement